PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

50.09 0.17 −0.34%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

PACS Group, Inc. (PACS) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, PACS Group, Inc. (PACS) trades at a EV/EBITDA of 16.2×. Over the past ten years it has ranged from 4.2× (September 2025) to 44.6× (November 2024); the current reading is higher than 72% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 16.7× 37.22%
FY2024 12.2× (17.71%)
FY2023 14.8× 0.00%
FY2022 14.8× 0.00%
FY2021 14.8× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.5× (5.04%)
Jun 2026 14.2× 24.09%
Mar 2026 11.4× (31.56%)
Dec 2025 16.7× 179.75%
11 more quarters

Against its own ten years

Low 4.2× High 44.6×
Ten-year median 14.3×
Current reading's percentile 72

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PACS